Efficacy and safety outcomes of ticagrelor compared with clopidogrel in Chinese elderly patients with acute coronary syndrome

Overview of attention for article published in Therapeutics and Clinical Risk Management, July 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

policy: 2 policy sources

twitter: 3 X users

Citations

dimensions_citation: 43 Dimensions

Readers on

mendeley: 64 Mendeley

Summary Policy documents X Dimensions citations

So far, Dimensions has found 43 publications that cite this research output.

43

The most recent citing publications are shown below. View all 43 publications that cite this research output on Dimensions.

Ticagrelor versus Adjusted‐Dose Prasugrel in Acute Coronary Syndrome with Percutaneous Coronary Intervention

Article in Clinical Pharmacology & Therapeutics (February 2024)

Net clinical benefit of dual antiplatelet therapy in elderly patients with acute coronary syndrome: A systematic review and meta‐analysis

Article in Catheterization and Cardiovascular Interventions (September 2023)

The efficacy and safety of the prasugrel, ticagrelor, and clopidogrel dual antiplatelet therapies following an acute coronary syndrome: A systematic review and Bayesian network meta-analysis

Preprint in medRxiv (August 2023)